CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-20 | CAMPANA DARIO 10% owner | Sale | −12,606 | $0.40 | $5K | 4,352,741 |
| 2020-04-17 | CAMPANA DARIO 10% owner | Sale | −65,540 | $0.39 | $26K | 4,365,347 |
| 2020-04-16 | CAMPANA DARIO 10% owner | Sale | −600 | $0.38 | $230 | 4,430,887 |
| 2020-04-15 | CAMPANA DARIO 10% owner | Sale | −82,782 | $0.38 | $32K | 4,431,487 |
| 2020-04-14 | CAMPANA DARIO 10% owner | Sale | −54,967 | $0.40 | $22K | 4,558,275 |
| 2020-04-14 | CAMPANA DARIO 10% owner | Sale | −44,006 | $0.40 | $18K | 4,514,269 |
| 2020-04-09 | CAMPANA DARIO 10% owner | Sale | −420,292 | $0.33 | $138K | 4,613,242 |
| 2020-04-08 | CAMPANA DARIO 10% owner | Sale | −100 | $0.35 | $35 | 5,033,534 |
| 2020-04-07 | CAMPANA DARIO 10% owner | Sale | −11,400 | $0.35 | $4K | 5,033,634 |
| 2020-04-06 | CAMPANA DARIO 10% owner | Sale | −50,080 | $0.35 | $18K | 5,045,034 |
| 2020-04-06 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +49,887 | $0.22 | $11K | 49,887 |
| 2020-04-06 | Ferrante Karen Jean Director | Grant or award · Stock Option (Right to Buy) | +54,422 | $0.22 | $12K | 54,422 |
| 2020-04-06 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +86,735 | $0.22 | $19K | 86,735 |
| 2020-04-06 | Aldag Jorn Director | Grant or award · Stock Option (Right to Buy) | +56,690 | $0.22 | $13K | 56,690 |
| 2020-02-11 | Sachs Jessica Chief Medical Officer | Grant or award · Stock Option | +133,200 | 133,200 | ||
| 2020-02-11 | Osborne Matthew Scott Chief Financial Officer | Grant or award · Stock Option | +160,400 | 160,400 | ||
| 2020-02-11 | HODGE GEOFFREY Chief Technical Officer | Grant or award · Stock Option | +112,400 | 112,400 | ||
| 2020-02-11 | Green John L. See Remarks | Grant or award · Stock Option | +64,400 | 64,400 | ||
| 2020-02-11 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option | +153,600 | 153,600 | ||
| 2020-01-02 | Ferrante Karen Jean Director | Grant or award · Stock Option (Right to Buy) | +26,480 | $0.45 | $12K | 26,480 |
Page 11 of 14 · 268 trades